Related Experiment Video
Updated: Jun 15, 2026
07:15
Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
Recent progress in congenital long QT syndrome
1Department of Medicine, College of Physicians and Surgeons, Columbia University Medical Center, New York, New York 10032, USA.
Current Opinion in Cardiology
|March 13, 2010
Summary
Genetic testing for Long QT syndrome (LQTS) allows for subtype-specific management. Research is advancing towards mutation-specific treatment by linking ion channel defects to patient phenotypes.
Area of Science:
- Cardiology
- Genetics
- Molecular Biology
Background:
- Congenital Long QT syndrome (LQTS) is a significant cause of sudden cardiac death.
- Twelve genes are currently identified as causative for congenital LQTS.
- Advances in genetic testing have improved understanding of genotype-phenotype correlations.
Purpose of the Study:
- To review recent findings on the link between ion channel mutations and LQTS phenotypes.
- To explore the implications of genetic testing for LQTS management.
Main Methods:
- Literature review of recent studies on LQTS genetics and clinical phenotypes.
- Analysis of genotype-phenotype correlations in congenital LQTS.
Main Results:
- LQTS management has evolved to be subtype-specific, driven by genetic testing availability.
- Studies increasingly link specific LQTS mutations to distinct clinical phenotypes.
- Variable penetrance and pleiotropic expression complicate direct genotype-phenotype correlation, as seen in SCN5A mutations.
Conclusions:
- Genotype information enables subtype-specific LQTS management.
- The findings support the potential for mutation-specific LQTS treatment based on functional characteristics.
- Further research is needed to elucidate mechanisms of variable penetrance and pleiotropic expression in LQTS.
Related Concept Videos
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
01:28Mechanism of Cardiac Arrhythmias
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
01:18Patch Clamp
Many fundamental cell functions such as muscle contraction and nerve transmission rely on the electrical signals produced by the movement of positively and negatively charged ions across the cell membrane. One competent method to record current flowing across the whole cell or single ion channel is the patch-clamp technique.
In this method, a glass micropipette containing electrolyte solution is tightly sealed against a small portion of the cell membrane. As a result, a patch of the cell...
In this method, a glass micropipette containing electrolyte solution is tightly sealed against a small portion of the cell membrane. As a result, a patch of the cell...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:30Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...